medicine for lung cancer - Page 14 of 67

MEFTINIB 250MG TAB

MEFTINIB 250MG TAB is an Over-the-counter (OTC) drug. MEFTINIB 250MG TAB is composed of: GEFITINIB (250.0 MG)

MEDITREX 7.5MG TAB is a Schedule H drug. MEDITREX 7.5MG TAB is composed of: METHOTREXATE (7.5 MG)

MEDITREX 5MG TAB is a Schedule H drug. MEDITREX 5MG TAB is composed of: METHOTREXATE (5.0 MG)

MEDITREX 15MG TAB is a Schedule H drug. MEDITREX 15MG TAB is composed of: METHOTREXATE (15.0 MG)

MEDITREX 10MG TAB is a Schedule H drug. MEDITREX 10MG TAB is composed of: METHOTREXATE (10.0 MG)

MACLITAXEL 260MG INJ is a Schedule H drug. MACLITAXEL 260MG INJ is composed of: PACLITAXEL (260.0 MG)

LYFLOX O TAB is an Over-the-counter (OTC) drug. LYFLOX O TAB is composed of: ORNIDAZOLE (500.0 MG), GEFITINIB (200.0 MG)

LYFLOX A 400MG/60MG TAB is an Over-the-counter (OTC) drug. LYFLOX A 400MG/60MG TAB is composed of: AMBROXOL (400.0 MG), GEFITINIB (60.0 MG)

LOTEGATE EYE DPS is a Schedule H drug. LOTEGATE EYE DPS is composed of: LOTEPREDNOL (500.0 MG), GEFITINIB (3.0 MG)

LGS 400MG TAB is an Over-the-counter (OTC) drug. LGS 400MG TAB is composed of: GEFITINIB (400.0 MG)